Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration (Q36504830)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 2006
edit
Language Label Description Also known as
English
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
scientific article published on May 2006

    Statements

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit